M 1731 Tenofovir diphosphate, tetraammonium salt Click here for Typical Certificate of Analysis |
|
| (PMPApp, tetrammonium salt) | |
|
|
|
| Solid | 1 µmol $1465 |
| Screw cap v-vial - shipped on dry ice | 6 µmol $3955 |
M.W. 447.17 for free acid ![]() | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MG 135 Tenofovir diphosphate, tetraammonium salt, [adenine-13C5]- |
|
| (PMPApp, tetraammonium salt, [adenine-13C5]-) | |
|
|
|
| Solid | |
| Screw cap v-vial - shipped on dry ice | 2 µmol $1440 |
M.W. 452.14 for free acid ![]() | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1893 Tenofovir diphosphate, tetraammonium salt, [adenine-8-3H]- |
|
| Click here for Typical Certificate of Analysis | |
| (PMPApp, tetraammonium salt, [adenine-8-3H]-) | |
|
|
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 1 Ci(37 GBq)/mmol | 50 µCi (1.85 MBq) $1160 |
| NextGen V-Vial - shipped on dry ice | 250 µCi (9.25 MBq) $1970 |
M.W. 447.17 for free acid ![]() | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |